Evidence map›Paper›PMID 41095652›Full record

ArticleDiagnostics (Basel, Switzerland)2025

Prognostic Potential of Cancer-Associated Fibroblast Surface Markers and Their Specific DNA Methylation in Prostate Cancer.

Mark Jain, Olga Nesterova, Mikhail Varentsov, Nina Oleynikova, Aleksandra Vasiukova, Sofia Navruzova, German Golubin, Larisa Samokhodskaya, Pavel Malkov, Armais Kamalov

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mark JainUniversity Clinic, Lomonosov Moscow State University, 119992 Moscow, Russia.ORCID 0000-0002-6594-8113
Olga NesterovaUniversity Clinic, Lomonosov Moscow State University, 119992 Moscow, Russia.
Mikhail VarentsovFaculty of Fundamental Medicine, Lomonosov Moscow State University, 119992 Moscow, Russia.ORCID 0009-0000-8649-6681
Nina OleynikovaUniversity Clinic, Lomonosov Moscow State University, 119992 Moscow, Russia.
Aleksandra VasiukovaFaculty of Fundamental Medicine, Lomonosov Moscow State University, 119992 Moscow, Russia.ORCID 0009-0007-9156-8177
Sofia NavruzovaFaculty of Fundamental Medicine, Lomonosov Moscow State University, 119992 Moscow, Russia.ORCID 0009-0001-4334-9566
German GolubinFaculty of Fundamental Medicine, Lomonosov Moscow State University, 119992 Moscow, Russia.ORCID 0009-0000-8316-709X
Larisa SamokhodskayaUniversity Clinic, Lomonosov Moscow State University, 119992 Moscow, Russia.
Pavel MalkovUniversity Clinic, Lomonosov Moscow State University, 119992 Moscow, Russia.
Armais KamalovUniversity Clinic, Lomonosov Moscow State University, 119992 Moscow, Russia.

Funding

State Assignment of MSU Section 0708
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biochemical recurrencecancer-associated fibroblastsDNA methylationprognosisprognostic biomarkerprostate cancertumor microenvironment

Identifiers

PMID41095652
PMCPMC12524081

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.